Introduction
Intracellular phospholipase A (PEa2; EC 3.1.1.4) catalyses the hydrolysis of the ester bound at the sn-2 position of glycerophospholipids and is a key enzyme in the production of potent inflammatory mediators, including prostaglandins, leukotrienes and platelet activating factor. Recently, it has been demonstrated that mammalian PEA can be classified into at least three groups on the basis of their primary structure. Two of these groups are designated I-and II-PLA2, and are found in pancreatic juice and a variety of tissues other than pancreas, respectively. Both groups have a molecular mass of 14 kDa. The third group is present in the cytosolic fraction of various tissues and has a molecular weight of 85 kDa. Among these enzyme groups, only II-PLA has been considered to play an important role in the process of inflammation, for example, in rheumatoid arthritis or inflammatory bowel disease. In our previous studies, it was demonstrated that rat gingival cells had II-PLA activity and that this activity was induced by the inflammatory cytokines interleukin-l]3 (IL-113) and tumour necrosis factor-cz (TNF-00, but inhibited by the anti-inflammatory cytokine transforming-growth factor-]3 (TGF-[). 6, 7 In addition, we also demonstrated PLA activity in human gingival crevicular fluid (GCF) from patients with periodontal disease and indicated that this activity appeared to reflect periodontal disease conditions (active or resting), suggesting that its potential usefulness as a marker for the assessment of disease activity. However, the maximum volume of GCF was too small to determine whether the activity if contained belonged to the II-PLA2 group, even with the sensitive method we employed. Since 12 and an inhibitory protein such as C3dg. 13 Up to now it has not been clarified whether the elevated PEA2 activity in GCF and gingival tissue is due to an increase in enzyme concentration or to direct activation of the enzyme. Figure 2 shows 
